IP Library Granted Patent US 10,335,737
Granted Patent B2
US 10,335,737 · App. 15/552,447 · Granted Jul 2, 2019

Filtration assembly including spiral wound bioreactors and membrane modules positioned in separate pressure vessels

Inventors: Steven D. Jons (Eden Prairie, MN); Jon E. Johnson (Plymouth, MN); Steven Rosenberg (Shorewood, MN)
Assignee: DOW GLOBAL TECHNOLOGIES LLC
B01D61/04C02F3/1273B01D63/12B01D2311/04B01D2311/2688C02F1/441C02F1/442C02F2103/08C02F2201/004C02F2201/007C02F2203/006C02F2209/001C02F2209/03C02F2301/02C02F2303/20Y02W10/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,335,737
App. No.
15/552,447
Granted
Jul 2, 2019
Kind
B2
Abstract

A filtration assembly including: a hyperfiltration assembly including: a high pressure vessel including a feed port, concentrate port and permeate port, and a plurality of serially arranged spiral wound hyperfiltration membrane modules; a bioreactor assembly including: a low pressure vessel comprising a first and second port, and a plurality of spiral wound bioreactors located within the low pressure vessel with each bioreactor comprising a flat sheet having two opposing bio-growth surfaces and a feed spacer spirally wound about an axis; and a fluid flow pathway extending from a fluid feed source: into the first port of the low pressure vessel, through the bioreactors and out the second port of the low pressure vessel, and into the feed port of the high pressure vessel, through the membrane modules and out of the concentrate port and permeate port.

Claims (22)

1. A filtration assembly ( 86 ) comprising:

i) a hyperfiltration assembly ( 38 ) comprising:

a) a high pressure vessel ( 40 ) comprising a feed port ( 42 ), concentrate port ( 43 ) and permeate port ( 44 );

b) a plurality of serially arranged spiral wound hyperfiltration membrane modules ( 2 ) located within the high pressure vessel ( 40 ) and each comprising at least one membrane envelop wound ( 4 ) around a permeate tube ( 8 ) forming a permeate pathway to the permeate port ( 44 );

ii) a bioreactor assembly ( 72 ) comprising:

a) a low pressure vessel ( 73 ) comprising a first ( 80 ) and second ( 82 ) port,

b) a plurality of spiral wound bioreactors ( 52 ) located within the low pressure vessel ( 73 ) with each bioreactor comprising a flat sheet ( 54 ) having two opposing bio-growth surfaces ( 56 , 56 ′) and a feed spacer ( 58 ) spirally wound about an axis (Y) to form a cylindrical outer periphery extending along axis (Y) from a first end ( 60 ) to a second end ( 62 ) with an inlet scroll face ( 64 ) located near the first end ( 60 ) and an outlet scroll face ( 66 ) located near the second end ( 62 ) and center conduit ( 70 ), wherein the conduit ( 70 ) is in fluid communication with the flat sheet and feed spacer only through the inlet or outlet scroll faces ( 64 , 66 ), wherein the center conduits ( 70 ) of the bioreactors ( 52 ) are in fluid communication with each other and the second port ( 82 ); and

iii) a fluid flow pathway adapted for fluid connection with a fluid feed source ( 88 ) and passing:

a) into the first port ( 80 ) of the low pressure vessel ( 73 ), through the inlets of the scroll faces ( 64 ) and out of the outlet scroll faces ( 66 ) of the bioreactors ( 52 ), through the center conduits ( 70 ) and out the second port ( 82 ) of the low pressure vessel ( 73 ), and

b) into the feed port ( 42 ) of the high pressure vessel ( 40 ), through the spiral wound hyperfiltration membrane modules ( 2 ) and out of the concentrate port ( 43 ) and permeate port ( 44 ).

2. The filtration assembly ( 86 ) of claim 1 wherein the fluid flow pathway follows a parallel flow pattern through the bioreactors ( 52 ) of the bioreactor assembly ( 72 ) and a serial flow pattern through the membrane modules ( 2 ) of the hyperfiltration assembly ( 38 ).

3. The filtration assembly ( 86 ) of claim 1 wherein:

the low pressure vessel ( 73 ) defines a first ( 74 ) and second ( 76 ) chamber separated by a divider ( 78 ) wherein the first port ( 80 ) is in fluid communication with the first chamber ( 74 ) and the second port ( 82 ) is in fluid communication with the second chamber ( 76 );

the bioreactors ( 52 ) are positioned in a parallel arrangement within the low pressure vessel ( 73 ) with the inlet scroll face ( 64 ) of each bioreactor ( 52 ) in fluid communication with the first chamber ( 74 ) and the outlet scroll face ( 66 ) of each bioreactor ( 52 ) in fluid communication with the second chamber ( 76 ); and

the fluid flow pathway extends: a) into the first port ( 80 ) of the low pressure vessel ( 73 ), into the first chamber ( 74 ), through the inlet scroll face ( 64 ) and outlet scroll face ( 66 ) of the bioreactors ( 52 ), into the second chamber ( 76 ) of the low pressure vessel ( 73 ), and out of the second port ( 82 ) of the low pressure vessel ( 73 ), and b) into the feed port ( 42 ) of the high pressure vessel ( 40 ), through the spiral wound hyperfiltration membrane modules ( 2 ) and out of the concentrate port ( 43 ) and permeate port ( 44 ).

4. The filtration assembly ( 86 ) of claim 1 wherein: the low pressure vessel ( 73 ) comprises a cylindrical inner chamber ( 84 ) in fluid communication with the first ( 80 ) and second ( 82 ) port and the bioreactors ( 52 ) are positioned in a serial arrangement within the cylindrical inner chamber of the low pressure vessel ( 73 ).

5. The filtration assembly ( 86 ) of claim 1 comprising at least one microfiltration or ultrafiltration device located along the fluid flow pathway at a location including at least one of:

i) between the hyperfiltration assembly ( 38 ) and the bioreactor assembly ( 72 ), and

ii) between a fluid feed source ( 88 ) and the bioreactor assembly ( 72 ).

6. The filtration assembly ( 86 ) of claim 1 further comprising a plurality of hyperfiltration assemblies ( 38 ) each in fluid communication with the bioreactor assembly ( 72 ), wherein the fluid flow pathway extends from the second port ( 82 ) of the low pressure vessel ( 73 ) of the bioreactor assembly ( 72 ) and into the feed port ( 42 ) of each hyperfiltration assembly ( 38 ).

7. The filtration assembly ( 86 ) of claim 1 further comprising a plurality of bioreactor assemblies ( 52 ) each in fluid communication with the hyperfiltration assembly ( 38 ), wherein the fluid flow pathway extends from the second port ( 82 ) of each bioreactor assembly ( 72 ) and into the feed port ( 42 ) of the hyperfiltration assembly ( 38 ).

8. The filtration assembly ( 86 ) of claim 1 wherein the flat sheet ( 54 ) of the bioreactor ( 52 ) is permeable and the two opposing bio-growth surfaces ( 56 , 56 ′) are in fluid communication with each other.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2024
From: DOW GLOBAL TECHNOLOGIES LLC
To: THE DOW CHEMICAL COMPANY
Reel/Frame 069923/0030 →
CHANGE OF LEGAL ENTITY Recorded Sep 10, 2024
From: DDP SPECIALTY ELECTRONIC MATERIALS US, INC
To: DDP SPECIALTY ELECTRONIC MATERIALS US, LLC
Reel/Frame 068907/0881 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2024
From: THE DOW CHEMICAL COMPANY
To: DDP SPECIALTY ELECTRONIC MATERIALS US, INC
Reel/Frame 068922/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: JONS, STEVEN D.; ROSENBERG, STEVEN
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 048749/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: FILMTEC CORPORATION
To: DOW GLOBAL TECHNOLOGIES LLC
Reel/Frame 048749/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: JOHNSON, JON E.
To: FILMTEC CORPORATION
Reel/Frame 048749/0600 →
Continuity (2)
Provisional Application 62148365 · Apr 16, 2015
Related Publication 20180043309A1 · Feb 15, 2018
Cited By (1)
US 12,458,911